What Healthcare Organizations Need to Understand About the New AI Governance Standard

AI use in healthcare is moving faster than oversight, and that gap can turn into patient, privacy, and security risk fast.

If I boil the article down to its core, here’s the point: healthcare organizations need to treat AI governance as daily risk work, not a policy file. The two main standards in play are NIST AI RMF 1.0 and ISO/IEC 42001. One helps me run AI risk across use, review, and control. The other helps me build a formal management system around that work.

Here’s what I’d take away first:

• NIST AI RMF 1.0 focuses on four functions: Govern, Map, Measure, and Manage
• ISO/IEC 42001 adds a certifiable management-system structure
• These standards do not replace HIPAA, HITECH, or FDA rules
• In healthcare, AI risk often starts with:
  • PHI exposure
  • vendor black-box tools
  • bias in care decisions
  • model drift
  • EHR integration issues
  • shadow AI
  • nonhuman identities with too much access
• The article points to a few numbers that show why this matters now:
  • More than 40% of U.S. physicians were using OpenEvidence daily
  • 52% of organizations had nonhuman identities with critical excessive permissions
  • States introduced 250+ healthcare AI bills across 47 states in 2025
  • Colorado’s AI Act took effect on February 1, 2026

A simple way I’d frame it: if an AI tool touches patient data, clinical advice, scheduling, billing, imaging, or vendor systems, it needs named owners, access limits, review steps, logs, and written records.

Healthcare AI Governance - Risks, Compliance, and Frameworks Explained

sbb-itb-535baee

Quick comparison

The article’s bottom line is clear: I should inventory AI tools, assign owners, check BAAs and vendor rights, test high-risk systems, and move from one-time review to continuous monitoring.

1. What the AI governance standard landscape looks like for U.S. healthcare

Two frameworks matter most right now. NIST AI RMF 1.0 is the main U.S. framework for handling AI risk and trustworthiness. It centers on four functions: Govern, Map, Measure, and Manage. ISO/IEC 42001 is an international standard that sets requirements for building and improving an AI Management System, or AIMS. It also brings the documented process discipline many teams need as they move toward maturity and audit-readiness. ^[2]

"Consider using NIST AI RMF as your operating framework for risk and trustworthiness and treat ISO 42001 as a maturity and audit-readiness target." - Marty Barrack, Chief Legal and Compliance Officer, XiFin, Inc. ^[2]

That’s a useful way to see the relationship. One helps you run AI risk day to day. The other helps you build the process structure around it.

NIST AI RMF: Govern, Map, Measure, Manage

Each NIST function lines up with problems healthcare groups already deal with.

GOVERN is about culture and decision rights. Put simply: who gets to approve a clinical AI tool, and who can stop it if something looks off? MAP is more than keeping a list of tools. It looks at the actual use case: which patient groups may be affected, what kinds of mistakes the model could make, and what harm those mistakes could cause. MEASURE should happen over time, not just once at launch. That means checking model performance, drift, and subgroup differences on a regular basis. A model trained on pre-pandemic data, for instance, may not work well with today’s patient population. MANAGE is where teams act on those signals early and document residual risk decisions. ^[1]

How ISO/IEC 42001 complements NIST AI RMF

Where NIST is centered on operating risk and trustworthiness, ISO/IEC 42001 is centered on process. It asks organizations to establish, implement, and continually improve an AI Management System, with formal documentation that supports audit-readiness. ISO/IEC 23894 can help here too, because it gives guidance on fitting risk management into AI-related activities. ^[2]

These frameworks are not rivals. They work side by side.

How these standards connect to HIPAA, HITECH, and healthcare security obligations

AI governance frameworks do not replace current legal and regulatory duties. HIPAA, HITECH, and FDA rules for Software as a Medical Device (SaMD) still apply. AI simply adds new ways those duties can be missed.

When AI tools touch PHI, healthcare groups need to treat governance as part of third-party risk management. That matters even more because many vendor chatbots and ambient listening tools work like black boxes. You may get the output without seeing much of what happens under the hood. That’s why procurement and contracting need to sit inside the governance program, not off to the side as a separate technical check. ^[2]

The NIST MEASURE function also lines up with FDA post-market surveillance expectations for SaMD. ^[1] And there’s another issue many teams run into: staff may start using consumer AI tools for clinical or admin work on their own. That means organizations need policies for shadow AI and for the risk of unauthorized PHI exposure. ^[2]

2. How the standard changes healthcare cyber risk management

AI isn't just one more app to log in your software inventory. It brings risks that old-school software reviews often miss: model drift, biased outputs that can shape care decisions, and nonhuman identities with far too much access. So this isn't only a software-risk problem. It's also an access-control and workflow problem.

That’s where NIST AI RMF comes in. It turns broad standards into day-to-day controls teams can use. In plain terms, healthcare groups need to govern AI through access, data flow, and vendor controls.

Healthcare-specific AI risks to map first

You can’t control AI risk if you don’t know where it shows up. In healthcare, the first places to map are PHI exposure and data leakage, model bias that shifts care decisions for certain patient groups, model drift as clinical populations change over time, insecure links with EHRs and imaging platforms, supply-chain exposure from third-party vendors, and shadow AI.

Shadow AI is a big one because it slips around approval, logging, and PHI controls. That makes it easy to miss until something goes wrong.

Mapping AI risks to practical controls

Finding a risk only matters if someone acts on it. The simplest way to move from theory to action is to tie each risk to one owner and one control. The table below links common healthcare AI risks to the NIST AI RMF functions that fit them, along with controls teams can use right now.

How to integrate AI governance into existing risk and security programs

AI governance tends to break down when it lives outside normal team workflows. Only 5% of custom enterprise AI tools reach production when organizations lack workflow-integrated oversight. ^[2]

The fix is pretty direct: build AI governance into GRC, procurement, and clinical review instead of treating it like a side project. CISO, compliance, clinical, legal, procurement, and operations teams each own part of the control stack. That shared setup lays the groundwork for the governance, validation, and documentation work that comes next.

3. Core requirements for safe and compliant AI adoption

Safe AI adoption needs more than a green light at launch. It needs clear owners, written controls, and proof before and after deployment. In practice, there are four evidence gates for adoption: owner, access, validation, and record.

Governance roles, accountability, and decision rights

AI decisions in healthcare can't sit with one team alone. Clinical, security, privacy, legal, informatics, and IT all have a say. The table below shows who owns what, tied to the NIST AI RMF Govern function.

These decision rights shouldn't live on paper only. They should shape every vendor review and every data-access call.

PHI protection and third-party AI oversight

A signed BAA is the floor, not the ceiling, before any vendor gets ePHI. If a vendor won't sign one, don't use that tool with patient data. It's that simple.

For FDA-cleared tools, make sure use stays within the cleared indication. Teams should also track updates through the vendor's Predetermined Change Control Plan (PCCP).

Contractual audit rights in procurement agreements matter too. They give you oversight that goes past the first vendor and reaches into the broader service chain.

Once vendor and PHI controls are in place, the next step is straightforward: show that the system works safely in actual use.

Validation, monitoring, and documentation that hold up to review

Pre-deployment validation should cover reliability, safety, bias management, and clinical or medical device workflow review. Before any AI system goes live, teams need audit-ready evidence that it performs reliably across the patient populations it will serve.

After deployment, don't rely on one-time checks. Watch for model drift through ongoing logs, not point-in-time reviews. Keep the AI asset inventory current, refresh risk analyses on a regular basis, and log AI-related incidents.

"If you don't map your regulatory obligations early, you will pay for it later - in remediation, contract changes, and delayed deployment." - Marty Barrack, Chief Legal and Compliance Officer, XiFin, Inc. ^[2]

The review also needs a permanent record. The artifacts below are the core evidence that should exist for any AI system used in a healthcare setting.

Update these artifacts whenever the model, vendor, or risk profile changes.

4. A practical implementation roadmap for healthcare organizations

Once governance, inventory, and documentation basics are in place, healthcare organizations need a 90-day operating plan. For a U.S. health system, that timeline is realistic.

A 90-day starting plan for governance, inventory, and risk assessment

Month 1 - Govern foundation. After roles, controls, and documentation are set, the next move is simple: put the governance structure to work. Appoint an AI governance lead with executive backing from the CIO, CISO, CMO, or COO. Then form a cross-functional AI Governance Working Group that includes clinical, IT/security, privacy/compliance, risk, vendor management, and ethics leaders.

That ethics seat matters more than many teams realize. A Censinet/CHIME analysis cited in a healthcare AI governance guide found that ethics or bioethics professionals are missing from about 75% of current healthcare AI governance committees. ^[7]

The group’s first deliverable should be an AI Governance Policy. Keep it short - about 3 to 6 pages. It should define scope, decision rights, and risk tiers. A simple four-tier model works well:

• Low
• Medium
• High
• Critical

Use those tiers as the starting point for reviews and approvals. ^[3][5][8]

Month 2 - Inventory and risk classification. Next, launch a system-wide inventory campaign across the places where AI is most likely to show up: EHR and clinical decision support, radiology, pathology, pharmacy, scheduling, contact center, and revenue cycle.

For each AI system, document its owner, vendor, data use, PHI exposure, deployment environment, and contract or BAA status. Every system should have a named owner who is accountable for controls and monitoring.

Once the inventory is built, classify each system into a risk tier. Then move the top 10 to 20 high-impact tools to the front of the line for review. For AI tools already in production, log inputs, outputs, overrides, and error rates. That gives the organization a baseline for day-to-day oversight. ^[3][5][8]

Month 3 - Assess, approve, and document. Now it’s time to review the high-priority systems. Use a checklist that covers security, privacy, bias, explainability, vendor risk, resilience, and human oversight.

For each system, record one of three decisions: approve, conditionally approve, or hold. Then create a model card, or a similar record, that lays out the system’s purpose, inputs, outputs, limits, training data sources, and monitoring plan. Incidents should flow into existing patient safety and security workflows rather than sit in a separate side process. ^[3][4][6][8]

By day 90, the organization should have a visible AI inventory, a formal governance process, initial risk tiering, and a repeatable intake-and-assessment workflow.

Using Censinet to operationalize AI oversight at scale

Once that baseline is in place, centralized workflows make it much easier to scale the program without losing control.

Censinet RiskOps™ centralizes AI policies, risks, and tasks across governance, security, privacy, and vendor management. Censinet AI™ speeds assessment work by summarizing evidence, organizing risk information, and routing findings to the right reviewers while keeping human approval in place. Censinet Connect™ extends oversight into fourth-party exposure and vendor risk reviews.

The big advantage is straightforward: AI oversight stays inside existing risk and security workflows.

Conclusion: What healthcare leaders should do next

The core message is simple: after governance, inventory, and validation, the next move is to make AI oversight part of day-to-day risk management. NIST AI RMF and ISO/IEC 42001 give teams a solid starting point that lines up with HIPAA and HITECH. But a framework on paper isn't enough. It has to show up in daily work through clear ownership, controls, and steady monitoring.

AI regulation is tightening fast. State legislatures introduced more than 250 healthcare AI bills in 47 states in 2025, and Colorado's AI Act took effect on February 1, 2026. ^[9]

That means healthcare leaders should get concrete:

• Assign named owners
• Verify BAA coverage
• Lock in vendor audit rights and data-use limits
• Move monitoring from point-in-time checks to continuous oversight

That's how healthcare cyber risk management turns into AI governance in practice.

Organizations that put these controls in place now will be in a better position to use AI safely and show regulators, patients, and partners that the right guardrails are in place.

FAQs

Which AI tools should we review first?

Use a formal intake process to assign a risk tier to every AI system. Start with tools that handle protected health information, support clinical or diagnostic decisions, or affect day-to-day operations.

Review high-risk, patient-facing, or autonomous systems first. Hold in-house and third-party tools to the same governance standards, with extra scrutiny for vendors that lack documented change control plans or operate in tightly regulated areas such as FDA-regulated software as a medical device.

How does AI governance fit with HIPAA and FDA rules?

AI governance ties AI use to HIPAA and FDA rules through a risk-based process.

For HIPAA, that means applying privacy and security controls to PHI. In practice, this includes BAAs, role-based access, and audit logs.

For the FDA, the focus shifts to the safety of AI used as Software as a Medical Device. That includes FDA clearance, Good Machine Learning Practice, and oversight for updates and performance drift.

What evidence should we keep for each AI system?

Keep a complete set of records for each AI system so your team is ready for audits and compliance checks. That record set should include governance charters, incident intervention records, ONC HTI-1 source-attribute logs, and SBOMs.

It should also cover the day-to-day details that matter when someone needs to retrace what happened: intended use, patient impact, workflow placement, validation thresholds, model versions, input hashes, confidence scores, reviewer identities, decision rationales, bias assessments, performance drift monitoring, approval paths, and tamper-proof audit logs kept for at least six years.

Related Blog Posts

• Clinical Intelligence: Using AI to Improve Patient Care While Managing Risk
• Board-Level AI: How C-Suite Leaders Can Master AI Governance
• AI Is Moving Faster Than Healthcare Governance and That’s the Problem
• The New Front Line in Healthcare Cybersecurity Is AI Governance